Ulinastatin for injection
Function and Efficacy
This product is a refined glycoprotein extracted from human urine and is a protease inhibitor. It has the function of inhibiting the activity of various pancreatic enzymes such as trypsin and is often used in the treatment of pancreatitis. In addition, this product has the functions of stabilizing lysosomal membranes, inhibiting the release of lysosomal enzymes and inhibiting the production of myocardial inhibitory factors, so it can be used in the rescue treatment of acute circulatory failure.
Ingredients
Chemical name: The main ingredient of this product is ulinastatin, a glycoprotein separated and purified from human urine, which is a protease inhibitor.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| UlinastatinIngredients |
Inhibit the activity of various pancreatic enzymes such as trypsin, stabilize lysosomal membranes, inhibit the release of lysosomal enzymes, and inhibit the production of myocardial inhibitory factors, etc. More |
80449-31-6 | 2 |
Appearance
This product is white or slightly yellow freeze-dried block or powder.
Indication
1Acute pancreatitis; 2Chronic recurrent pancreatitis; 3Rescue and auxiliary medication for acute circulatory failure.
Usage and Dosage
1. Acute pancreatitis and chronic recurrent pancreatitis: 100,000 units dissolved in 500ml 5% glucose injection or injection for intravenous drip in the initial stage, each drip for 1 to 2 hours, 1 to 3 times a day, and then reduce the dosage as the symptoms subside; 3. Acute circulatory failure: 100,000 units dissolved in 500ml 5% glucose injection or sodium chloride injection for intravenous drip, each drip for 1 to 2 hours, 1 to 3 times a day, or 100,000 units dissolved in 5-10ml sodium chloride injection for slow intravenous injection 1 to 3 times a day. The dosage can be appropriately increased or decreased according to age and symptoms.
Adverse Reactions
1. Blood system: occasionally leukopenia or eosinophilia; 2. Digestive system: occasionally nausea, vomiting, diarrhea, occasionally increased AST and ALT; 3. Injection site: occasionally vascular pain, redness, itching, rash, etc.; 4. Occasionally allergic reactions occur. If allergic symptoms occur, the drug should be stopped immediately and treated appropriately.
Precautions
It is contraindicated for those who are allergic to this product.
Drug Interactions
Avoid mixing this product with gabexate or gelobulin preparations.
Storage
Keep tightly closed in a cool and dry place.
Packaging Specification
100,000 units
Manufacturer
-
Founded in:
1993-03-25 -
Address:
No. 89, Gaopu Road, Tianhe Gaotang Science and Technology Industrial Park, Tianhe District, Guangzhou -
Tax NO.:
91440101190490505C -
Registered Funds:
100 million yuan -
Website:
-
Email: